Publications

Export 138978 results:
Sort by: Author Title Type [ Year (Desc)]
2010
Bukasov, R., T. A. Ali, P. Nordlander, and J. S. Shumaker-Parry, "Probing the plasmonic near-field of gold nanocrescent antennas", Acs Nano, vol. 4, no. 11: American Chemical Society, pp. 6639–6650, 2010. Abstract
n/a
Bukasov, R., T. A. Ali, P. Nordlander, and J. S. Shumaker-Parry, "Probing the plasmonic near-field of gold nanocrescent antennas", Acs Nano, vol. 4, no. 11: American Chemical Society, pp. 6639–6650, 2010. Abstract
n/a
Riad, S. A., H. M. Safaa, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 1. Productive performance and economic efficiency", JOURNAL OF DAIRY SCIENCE, vol. 93: ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, pp. 813-813, 2010. Abstract
n/a
Riad, S. A., H. M. Safaa, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 1. Productive performance and economic efficiency", JOURNAL OF POULTRY SCIENCE, vol. 89, no. Suppl. 1: ELSEVIER SCIENCE INC, pp. 491, 2010. Abstract
n/a
Riad, S. A., H. M. Safaa, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 1. Productive performance and economic efficiency", JOURNAL OF POULTRY SCIENCE, vol. 89, no. Suppl. 1: ELSEVIER SCIENCE INC, pp. 491, 2010. Abstract
n/a
Riad, S. A., H. M. Safaa, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 1. Productive performance and economic efficiency", JOURNAL OF DAIRY SCIENCE, vol. 93: ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, pp. 813-813, 2010. Abstract
n/a
Safaa, H. M., S. A. Riad, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 2. Immune response and slaughter traits", JOURNAL OF DAIRY SCIENCE, vol. 93: ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, pp. 546-547, 2010. Abstract
n/a
Safaa, H. M., S. A. Riad, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 2. Immune response and slaughter traits", JOURNAL OF POULTRY SCIENCE, vol. 89, no. Suppl. 1: ELSEVIER SCIENCE INC, pp. 546–547, 2010. Abstract
n/a
Safaa, H. M., S. A. Riad, F. R. Mohamed, S. S. Siam, and H. A. El-Minshawy, "Probiotic, prebiotic and yeast supplementation in broiler diets from 1 to 42 days of age: 2. Immune response and slaughter traits", JOURNAL OF DAIRY SCIENCE, vol. 93: ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, pp. 546-547, 2010. Abstract
n/a
Wafi, M. S., M. R. Shahin, and A. A. Hassan, "Processing Tomato cultivar evaluation in Al-Ain, UAE", Emirates Journal of Food and Agriculture, vol. 2, no. 1, 2010. Abstract
n/a
, "PROCOLLAGEN type III Propeptide Levels among Preterm Infants in Neonatal Intensive Care Unit.", The Egyptian Journal of Neonatology, 2010.
Mansour, H. A., E. I. El-Maadawy, and I. Z. Othman, "Production of sunflower (Helianthus annuus L.) as a flowering pot plant using different potting media and growth retardant treatments.", Bulletin of Faculty of Agriculture, Cairo University, vol. 61, issue 1: Faculty of Agriculture, Cairo University, pp. 33-43, 2010. Abstract
n/a
Ballester-Bolinches, A., R. E. Romero, and M. Asaad, Products of finite groups, , vol. 53: Walter de Gruyter, 2010. Abstract
n/a
Overbeek, R., R. Aziz, D. Bartels, T. Disz, R. Edwards, S. Gerdes, C. Henry, G. Olsen, R. Olson, A. Osterman, et al., "Programmatic Access to the SEED Data Via the Network", Paper Draft/ Pre-Print, 2010. Abstract
n/a
Shanan, N. T., K. S. Emara, and O. S. Barakat, "Prolonging Vase Life of Carnation Flowers Using Natural Essential Oils and its Impact on Microbial Profile of Vase Solutions.", Australian Journal of Basic and Applied Sciences,, vol. 4, issue 8, pp. 3559-3574, 2010. Abstract
n/a
A. M., G. A. D. A. L. L. A., G. A. L. A. L. Y. G. M., Ismail M. M., E. L. D. E. G. W. Y. S. A., H. A., and L. MAMDOH MOHAMED HAMED, "Proper Management Of Irrigation Water And Nitrogen Fertilizer To Improve Spinach Yield And Reserve Environment Using 15N Tracer Technique", Isotope and Radiation Research, vol. 42, no. 10: https://inis.iaea.org/search/search.aspx?orig\_q=RN%3A42015250, pp. 387–400, 2010. Abstract
n/a
A. M., G. A. D. A. L. L. A., G. A. L. A. L. Y. G. M., Ismail M. M., E. L. D. E. G. W. Y. S. A., H. A., and L. MAMDOH MOHAMED HAMED, "Proper Management Of Irrigation Water And Nitrogen Fertilizer To Improve Spinach Yield And Reserve Environment Using 15N Tracer Technique", Isotope and Radiation Research, vol. 42, no. 10: https://inis.iaea.org/search/search.aspx?orig\_q=RN%3A42015250, pp. 387–400, 2010. Abstract
n/a
Mohamed, A. A., A. A. Khalil, and H. E. S. El Beltagi, "Propiedades antioxidantes y antimicrobianas de la rosa de Jerico (Anastatica hierochuntica) y duma (Hyphaene thebaica)", Grasas y aceites, vol. 61, issue 1: Instituto de la Grasa, pp. 67-75, 2010. Abstract
n/a
Ellatif, M. A. M., and N. R. Darwish, "Proposed approach to Evaluate Effect of e-CRM on Customers' Satisfaction of e-Commerce Websites", International Journal of Intelligent Computing and Information Sciences - IJICIS, vol. 10, no. 2: Ain Shams University, 2010. Abstract
n/a
Emary, E. M., K. M. El-Saied, and H. M. Onsi, "A proposed multi-scale approach with automatic scale selection for image change detection", The Egyptian Journal of Remote Sensing and Space Science, vol. 13, no. 1: Elsevier, pp. 1–10, 2010. Abstract
n/a
Aboulghar, M. A., L. M. Mourad, H. G. Al-Inany, M. M. Aboulghar, R. T. Mansour, and G. A. Serour, "Prospective randomized study for hydrotubation versus no hydrotubation before intrauterine insemination in unexplained infertility", Reproductive Biomedicine Online, vol. 20, pp. 543–546, 2010. Abstract
n/a
Barsoum, M. S., M. M. El Mongi, E. M. Khalil, H. E. Eisa, I. M. Hamed, and G. A. Attia, "Prospective randomized trial comparing postoperative adjuvant concurrent versus sequential hormonal and different radiation fractionation schedule in breast cancer patients.", ASCO Annual Meeting Proceedings, vol. 28, no. 15\_suppl, pp. 544, 2010. Abstract
n/a
Aboulghar, M., waleed saber, Y. Amin, M. Aboulghar, R. Mansour, and G. Serour, "Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.", Fertility and sterility, vol. 94, issue 6, pp. 2332-4, 2010. Abstract

In a randomized study comparing purified urinary FSH with recombinant FSH for IVF/intracytoplasmic sperm injection in patients with polycystic ovary syndrome, there was no significant difference between the mean total dose of FSH used, duration of stimulation, number of retrieved oocytes, number of mature oocytes, number of embryos transferred, or the ongoing pregnancy rate between the two groups. However, there were significantly more fertilized oocytes, a higher fertilization rate, more top-quality embryos, and more cryopreserved embryos in the urinary FSH group.

Zaghloul, M. S., R. Boutrus, H. El-Hossieny, Y. AbdelKader, I. El-Attar, and M. Nazmy, "A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.", International journal of clinical oncology, vol. 15, issue 4, pp. 382-9, 2010. Abstract

BACKGROUND: Zoledronic acid treatment reduces the incidence of skeletal-related events (SREs) in patients with bone metastases from breast, lung, and urologic cancers including prostate and renal cancer. The aim of this study was to evaluate the effect of zoledronic acid on SREs in patients with bone metastases from bladder cancer.

PATIENTS AND METHODS: Patients with bone metastases from bladder cancer who were receiving palliative radiotherapy were randomized to placebo or zoledronic acid (4 mg intravenous monthly) for 6 months.

RESULTS: The patients (n = 40) were evenly distributed between the two treatment groups, and the baseline demographics of the two groups were similar. The follow-up varied from 8 to 65 weeks (median 24 weeks). Compared with patients receiving placebo, those receiving zoledronic acid had a lower mean incidence of SREs (2.05 +/- 1.0 vs. 0.95 +/- 0.9, respectively), and a larger proportion did not experience an on-study SRE (2 vs. 8 patients, respectively). Zoledronic acid also prolonged the median time to first SRE compared with the placebo (16 vs. 8 weeks, respectively). Multiple event analysis of SREs revealed that zoledronic acid decreased the risk of SRE development by 59% (hazard ratio 0.413). Zoledronic acid also increased the 1-year survival rate compared with placebo (36.3 +/- 11.2 vs. 0%, respectively). Zoledronic acid was generally well tolerated in our patient population.

CONCLUSIONS: Zoledronic acid therapy decreased the incidence of SREs and improved the 1-year survival rate of patients with bone metastases from bladder cancer, potentially through its anticancer activity.

Zaghloul, M. S., R. Boutrus, H. El-Hossieny, Y. AbdelKader, I. El-Attar, and M. Nazmy, "A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.", International journal of clinical oncology, vol. 15, issue 4, pp. 382-9, 2010. Abstract

BACKGROUND: Zoledronic acid treatment reduces the incidence of skeletal-related events (SREs) in patients with bone metastases from breast, lung, and urologic cancers including prostate and renal cancer. The aim of this study was to evaluate the effect of zoledronic acid on SREs in patients with bone metastases from bladder cancer.

PATIENTS AND METHODS: Patients with bone metastases from bladder cancer who were receiving palliative radiotherapy were randomized to placebo or zoledronic acid (4 mg intravenous monthly) for 6 months.

RESULTS: The patients (n = 40) were evenly distributed between the two treatment groups, and the baseline demographics of the two groups were similar. The follow-up varied from 8 to 65 weeks (median 24 weeks). Compared with patients receiving placebo, those receiving zoledronic acid had a lower mean incidence of SREs (2.05 +/- 1.0 vs. 0.95 +/- 0.9, respectively), and a larger proportion did not experience an on-study SRE (2 vs. 8 patients, respectively). Zoledronic acid also prolonged the median time to first SRE compared with the placebo (16 vs. 8 weeks, respectively). Multiple event analysis of SREs revealed that zoledronic acid decreased the risk of SRE development by 59% (hazard ratio 0.413). Zoledronic acid also increased the 1-year survival rate compared with placebo (36.3 +/- 11.2 vs. 0%, respectively). Zoledronic acid was generally well tolerated in our patient population.

CONCLUSIONS: Zoledronic acid therapy decreased the incidence of SREs and improved the 1-year survival rate of patients with bone metastases from bladder cancer, potentially through its anticancer activity.